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8 ABSTRACT: Recent achievements in the area of tissue
9 engineering (TE) have enabled the development of three-
10 dimensional (3D) cell-laden hydrogels as in vitro platforms
11 that closely mimic the 3D scenario found in native tissues.
12 These platforms are extensively used to evaluate cellular
13 behavior, cell−cell interactions, and tissue-like formation in
14 highly deﬁned settings. In this study, we propose a scalable and
15 ﬂexible 3D system based on microsized hydrogel ﬁbers that
16 might be used as building blocks for the establishment of 3D
17 hydrogel constructs for vascularized bone TE applications. For
18 this purpose, chitosan (CHT) coated κ-carrageenan (κ-CA)
19 microﬁbers were developed using a two-step procedure
20 involving ionotropic gelation (for the ﬁber formation) of κ-CA and its polyelectrolyte complexation with CHT (for the
21 enhancement of ﬁber stability). The performance of the obtained ﬁbers was assessed regarding their swelling and stability
22 proﬁles, as well as their ability to carry and, subsequently, promote the outward release of microvascular-like endothelial cells
23 (ECs), without compromising their viability and phenotype. Finally, the possibility of assembling and integrating these cell-laden
24 ﬁbers within a 3D hydrogel matrix containing osteoblast-like cells was evaluated. Overall, the obtained results demonstrate the
25 suitability of the microsized κ-CA ﬁbers to carry and deliver phenotypically apt microvascular-like ECs. Furthermore, it is shown
26 that it is possible to assemble these cell-laden microsized ﬁbers into 3D heterotypic hydrogels constructs. This in vitro 3D
27 platform provides a versatile approach to investigate the interactions between multiple cell types in controlled settings, which
28 may open up novel 3D in vitro culture techniques to better mimic the complexity of tissues.
1. INTRODUCTION
29 In the past decade, tissue engineering (TE) has emerged as a
30 multidisciplinary ﬁeld at the interface of medicine, biology, and
31 engineering, aiming at fabricating tissue-like biological con-
32 structs.1 However, the lack of a vasculature that can sustain the
33 nutrients and oxygen demands within the tissue-engineered
34 construct is a major limiting factor in creating thick artiﬁcial
35 tissues.2 Thus, developing vessel-like networks based on
36 endothelial cells (ECs), as integrated templates within TE
37 constructs,3 would be essential for creating real-size replicas of
38 tissues or organs.4,5
39 Hydrogels have been proven to provide ideal mimics of cellular
40 matrices, as their hydrated state resembles that of native
41 extracellular matrix (ECM),6 and their high permeability to
42 oxygen, nutrients, and metabolites diﬀusion7 enables cell
43 encapsulation. Additionally, natural-origin hydrogels showed
44 high potential in the TE ﬁeld, due to their chemistry and
45 properties similar to ECM.8 Several processing methodologies
46 such as prototyping/printing,9 microﬂuidics,10 and photo-
47 litography11 have been used to develop vessel-like architectures
48 based on ECs-loaded hydrogels that exhibit microsized features
49 (∼50 μm11 to 1 mm9). However, these methods often require
50sophisticated equipment and elaborated experimental settings
51and reagents that frequently raise concerns over their
52cytotoxicity.12,13
53Wet spinning of hydrogels is a very simple and straightforward
54method, requiring minimal laboratorial utensils and short
55processing time. The wet spinning of hydrogel ﬁbers involves
56the extrusion of a polymer solution through a needle into a
57coagulation bath that triggers the cross-linking of the polymer
58into a ﬁber-like shape. This methodology has been successfully
59used to develop hydrogel ﬁbers based on several natural-origin
60polymers, such as alginate,14 collagen,15 gellan gum,16 chitosan,17
61or a combination of carrageenan and alginate.18
62Carrageenans (CAs) stand out, among other natural-origin
63polymers, as potential candidates for TE applications, due to
64their mild gelation properties and resemblance to glycosamino-
65glycans (GAGs), main components of the ECM of biological
66systems. CAs are highly sulfated linear polysaccharides with
67alternating repeating 3,6-anhydro-D-galactose and β-D-galactose-
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68 4-sulfated units, that provide structural support in several species
69 of marine red algae (class of Rhodophyceae). Due to the half-
70 ester sulfate moieties present on their backbone (their amount
71 determines the type of carrageenan that can be iota, lambda, or
72 kappa), CAs are strong anionic polymers. As a consequence, their
73 gelation occurs by ionic interactions with appropriate counter-
74 ions, such as K+, Na+, or Ca2+. Although these hydrophilic
75 polysaccharides have been widely used as emulsiﬁers, gelling,
76 thickening, or stabilizing agents in the food or pharmaceutical
77 industry,19 the intrinsic thixotropic behavior of κ-carrageenan (κ-
78 CA), in particular, has justiﬁed its exploitation as an injectable
79 matrix for the delivery of living cells18,20,21 and biomacromole-
80 cules.22,23 However, κ-CA hydrogels exhibit high swelling ratios
81 and mechanical instability in physiological conditions24 which
82 has motivated the development of several approaches to increase
83 their stability, such as chemical modiﬁcations with photo-cross-
84 linkable moieties,25 blending with other biopolymers,18,26
85 addition of nanocomposites to the polymer solution,23 and
86 formation of interpenetrating networks27 or polyelectrolyte
87 complexation (PEC) with polycations, such as chitosan
88 (CHT).28 Numerous studies have reported CHT-based PEC
89 systems with positive outcomes, in terms of stability as well as
90 cellular viability and behavior.29,30 Electrostatic interactions
91 between κ-CA and CHT have also been used for the
92 development of nanoparticles,31 beads,32 and layer-by-layer
93 systems.33
94 The present work reports on the development of κ-CA
95 microﬁbers coated with CHT using a two-step-procedure, and
96 on their potential as cell carriers and building blocks of 3D
97 constructs for vascularized bone tissue engineering. Therefore, in
98 a ﬁrst step, κ-CA ﬁbers of various diameters were obtained by wet
99 spinning. In a second step, in order to reinforce the ﬁbers and
100 enhance their stability in physiological relevant microenviron-
101 ment, κ-CA ﬁbers were coated with CHT, through the
102 electrostatic interaction between the polymers. The obtained
103 ﬁbers were then loaded with microvascular-like ECs obtained
104 from the SSEA-4+ subpopulation of adipose tissue stromal
105 vascular fraction, as described in a previous study.34 The
106 phenotype of the ECs was evaluated prior to and after
107 entrapment within the ﬁbers. Ultimately, envisioning a
108 heterotypic 3D bone TE construct with independent and
109 deﬁned microarchitectures, we proposed an innovative 3D
110 buildup of ECs loaded ﬁbers within a hydrogel matrix containing
111 osteoblast-like cells. In summary, this study showed that it is
112 possible to developed cell-laden κ-CA-based hydrogel ﬁbers that
113 exhibit high stability in prolonged culture conditions. Fur-
114 thermore, these ﬁbers could be stacked in a desired pattern and
115 successfully integrated into a 3D construct.
2. MATERIALS AND METHODS
116 2.1. Materials. κ-Carrageenan (κ-CA), potassium chloride (KCl),
117 and β-glycerophosphate disodium salt hydrate (βGP) were purchased
118 from Sigma, Germany. Reagent grade medium molecular weight
119 chitosan (CHT) (Sigma, Germany) with a 90% degree of acetylation
120 was used. Prior to use, CHTwas puriﬁed using a precipitation method.35
121 All other reagents were used as received.
122 2.2. Development of CHTCoated κ-CA Fibers. 2.2.1. Production
123 of κ-CA Fibers through Ionotropic Gelation. The κ-CA hydrogel ﬁbers
124 were obtained by wet spinning technique, which consisted of the
125 extrusion of the polymer solution through a needle immersed in a
126 coagulation bath, as previously described elsewhere.18 Brieﬂy, a 1.5%
127 (wt/v) κ-CA solution was prepared by dissolving the polymer in distilled
128 water at 50 °C and under constant stirring until complete dissolution
129 was achieved. Subsequently, the κ-CA solution was loaded into 5 mL
130syringes and κ-CA ﬁbers with diﬀerent diameters were obtained by
131extruding the polymeric solution through needles with diﬀerent gauges
132(18G to 27G), directly into a 5% (wt/v) KCl solution prepared in
133distilled water. The presence of K+ ions initiated the ionotropic gelation
134by counterbalancing the negative charges of κ-CA. The ﬁbers were
135allowed to harden in the coagulation bath for about 10 min, suﬃcient
136time for them to retain the shape. Finally, the ﬁbers were washed with
137phosphate buﬀered saline (PBS) in order to remove the excess of salt.
138Fibers obtained with needles of 25G and 27G were selected for all the
139subsequent assays.
1402.2.2. Optimization of the pH of the CHT Working Solution.
141Chitosan dissolves in acid solutions, which limits its use in the presence
142of living cells. Previous studies36 have shown that βGP, a weak base,
143increases the pH of CHT solutions, without jeopardizing its solubility.
144Therefore, in order to establish optimal conditions for the incorporation
145of cells, while enabling PEC, a curve of variation of pH with the addition
146of βGP to the CHT solution was obtained. For this purpose, a CHT
147solution was prepared by dissolving CHT in a 1% (v/v) acetic acid
148solution at a ﬁnal concentration of 0.5% (wt/v). In order to determine
149the degree to which the addition of βGP aﬀects the overall charge of
150CHT solution, zeta potential measurements were performed using a
151Malvern Zeta Sizer Nano ZS (Malvern Instruments, UK). Each sample
152was diluted in ultrapure water at a concentration of 0.1% (wt/v) and
153analyzed at 25 °C for 60 s.
1542.2.3. Coating of κ-CA Fibers through Polyelectrolyte Complex-
155ation with CHT. The κ-CA ﬁbers, previously obtained by ionotropic
156gelation, were immersed in the optimized CHT solution (0.5% (wt/v)
157and pH = 5.5) for 20 min, followed by several washing steps with PBS to
158remove the excess of CHT. The presence of the CHT coating was
159evaluated by staining the ﬁbers with Eosin Y (Sigma, Germany). Fibers
160without coating were used as negative control.
1612.3. Physico-Chemical Characterization of the Developed
162Fibers. 2.3.1. Swelling Kinetics. The inﬂuence of CHT coating on the
163swelling and stability of the developed κ-CA ﬁbers was determined by
164evaluating the ﬁbers’ water absorption kinetics and diameter variation
165upon immersion in culture medium for up to 21 days. The culture
166medium used for this purpose was Dulbecco’s Modiﬁed Eagle Medium
167(DMEM, Gibco, USA) supplemented with 10% (v/v) HiFBS (Gibco,
168USA) and 1% (v/v) antibiotic/antimycotic (penicillin/streptomycin,
169100 U/100 μg/mL, Gibco, UK). Envisioning the use of ﬁbers for cell
170encapsulation/culturing, the experimental parameters were set at
171physiological temperature (37 °C) and humidiﬁed atmosphere with
1725% of CO2. Medium was replenished every 3−4 days. Fibers (n = 3)
173were retrieved at days 7, 14, and 21, blotted with KimWipe paper to
174remove the excess of liquid, and weighed (MW). Sample’s ﬁnal weight
175(MDF) was determined upon lyophilization. The swelling kinetics was
176deﬁned as the ratio between the liquid uptake (MW−MDF) and the ﬁnal
177dry mass of polymer (MDF), according to eq 1.
= − ×M M Mmass swelling ratio ( )/ 100w DF DF 178(1)
179The ﬁnal diameter of the hydrogel ﬁbers was also measured applying
180software-measuring tools (NIH ImageJ software, http://rsbweb.nih.
181gov/ij/) to at least three micrographs of each sample.
1822.3.2. Morphological and Chemical Characterization. Concom-
183itant with the swelling behavior analysis, samples were retrieved for
184surface morphological evaluation and elemental analysis under a
185scanning electron microscope (SEM) coupled with energy-dispersive
186X-ray spectroscopy (EDX/EDS). Brieﬂy, ﬁbers were snap frozen in
187liquid nitrogen, transferred to microcentrifuge tubes, and freeze−dried
188overnight. The dried samples were carefully mounted on sample holders
189using double-sided carbon tape. Before being analyzed by SEM (Nano-
190SEM FEI Nova 200), the samples were gold sputter coated (Fisons
191Instruments, sputter coater SC502, UK). Elemental analysis was carried
192out with an energy dispersive spectrometer (EDAX-Pegasus X4M) on
193the same samples used for SEM. All observations/image acquisitions
194and measurements were made at an acceleration voltage of 15 kV.
1952.4. Isolation and Endothelial Diﬀerentiation of SSEA-
1964+hASCs. Human lipoaspirate samples from healthy donors were
197kindly provided by Hospital de Prelada (Porto, Portugal), under
198previously established protocols and with the informed consent of the
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199 patients. The selection of SSEA-4 positive cells (SSEA-4+hASCs)
200 residing within the stromal vascular fraction of the adipose tissue and
201 diﬀerentiation toward the endothelial lineage were performed according
202 to our previously published protocols.34 Brieﬂy, the SSEA-4+hASCs
203 were selected using immunomagnetic beads (Dynal M-450 Epoxy beads
204 from Dynal Biotech, Carlsbad, CA, USA) coated with SSEA-4 antibody
205 (Abcam, Cambridge, UK). Then, the selected SSEA-4+hASCs cells were
206 diﬀerentiated toward endothelial lineage by culturing them for 2 weeks
207 in endothelial cell growth medium, EGM-2 MV (Lonza, Switzerland),
208 containing 5% FBS and supplemental growth factors: hydrocortisone,
209 hFGF-B, ascorbic acid, gentamicin/amphotericin, VEGF, long R3-IGF-
210 1, hEGF, and heparin, at concentrations established by the
211 manufacturer.
212 2.5. SSEA-4+hASCs-Derived Endothelial Cells Encapsulation
213 within κ-CA Fibers. The κ-CA, CHT, and KCl solutions were
214 sterilized at 120 °C for 30 min. SSEA-4+hASCs-derived ECs at passage 3
215 were trypsinized and centrifuged, and further suspended in the κ-CA
216 solution at a ﬁnal cell density of 2 × 106 cells/mL. ECs loaded ﬁbers
217 (with and without CHT coating) were produced as described above.
218 The cell-loaded ﬁbers were then transferred to 24-well plates and
219 maintained in culture in EGM-2MV for 21 days, at 37 °C in a humidiﬁed
220 atmosphere with 5% CO2. Culture medium was replenished every 3−4
221 days.
222 In order to assess the maintenance of the phenotype of the SSEA-
223 4+hASCs derived ECs at 21 days of culture cell-loaded ﬁbers were
224 treated with 0.1% proteinase K (vWR, Portugal) in 1 mM EDTA
225 (Sigma, Germany), 50 mM TrisHCl (Sigma, Germany), and 1 mM
226 iodoacetamide buﬀer (Sigma, Germany), for 1 h at 37 °C, under
227 constant agitation, to release the cells from the ﬁbers. The cellular pellet
228 recovered after centrifugation (10 min, 400×g) was resuspended in
229 EGM-2 MV medium and plated into tissue culture ﬂasks. Cells were
230 cultured until reaching conﬂuence for further analysis, as described
231 below.
232 2.6. Characterization of the Constructs. 2.6.1. Microscopic
233 Analysis. Variations in the shape and diameter of the developed cell-
234 loaded ﬁbers (with or without CHT coating), as well as the potential
235 outward migration of the cells to the culture well, were examined using a
236 stereomicroscope (Stemi 1000, Zeiss, Germany) along the time of
237 culture.
238 2.6.2. Live−Dead Assay. At preselected time culturing points (1, 7,
239 14, and 21 days), cell-loaded ﬁbers were washed with PBS and incubated
240 with 4 μMcalcein-AM (Invitrogen, USA) for 40min followed by 10min
241 incubation with 1 μM propidium iodide (PI, Invitrogen, USA). Samples
242 (n = 3) were then washed and ﬁxed for 40 min in 10% formalin. After
243 ﬁxation, samples were washed with PBS and cell nuclei were
244 counterstained for 20 min with 4,6-diamidino-2-phenyindole dilactate
245 (DAPI, Sigma, Germany) and then washed three times with PBS.
246 Representative ﬂuorescent micrographs were acquired using the
247 Axioplan Imager Z1 ﬂuorescence microscope (Zeiss, Germany) and
248 the AxioVision 4.8 software (Zeiss, Germany). The quantiﬁcation of
249 cellular viability was measured by applying software-measuring tools
250(NIH ImageJ software, http://rsbweb.nih.gov/ij/) to at least three
251micrographs of each sample.
2522.6.3. Flow Cytometry. SSEA-4+hASCs-derived ECs, prior to and
253after encapsulation, were retrieved from cell culture ﬂasks using TrypLE
254Express (Invitrogen, USA). 5 × 105 cells were incubated for 30 min at 4
255°C with the following markers: CD45-FITC, CD34-PE, CD73-PE,
256CD31-APC (all from BD Pharmingen, USA), and CD105-FITC and
257CD90-APC (eBiosciences, USA) at a concentration of 6 μg/mL, as
258recommended by the manufacturer. After washing with PBS, the cells
259were resuspended in acquisition buﬀer (PBS containing 1% form-
260aldehyde and 0.1% sodium azide) and analyzed with a BDFACS-Calibur
261ﬂow cytometer (BD Biosciences, USA). A minimum of 2 × 105 events
262was acquired and gated in a forward versus side-scatter dot plot with a
263linear scale. Results were displayed in histogram plots created using
264CellQuest software (BD Biosciences, USA). The number of positive
265events for each cell-speciﬁc marker was expressed as a percentage of the
266total cell number.
2672.6.4. Matrigel Assay. SSEA-4+hASCs-derived ECs, at passage 2,
268were trypsinized and plated at a density of 3 × 104 cells/well in 48-well
269plates coated with 64 μL of Matrigel (BD Biosciences, USA). Cells were
270incubated for 4 h at 37 °C. One hour prior ﬁxation, 4 μM calcein-AM
271(Invitrogen, USA) was added to the wells. Upon ﬁxation, cell nuclei
272were counterstained with DAPI for 10min, and then washed three times
273with PBS. Three representative images were acquired under a
274ﬂuorescence microscope.
2752.7. Assembling the κ-CA Fibers into 3D Hydrogel Discs. Cell-
276laden ﬁbers containing SSEA-4+hASCs-derived ECs labeled with a GFP
277tag were transferred to a Petri dish and allowed to settle randomly. A
278freshly prepared κ-CA solution containing osteogenic diﬀerentiated
279SSEA-4+hASCs (obtained according to a method described else-
280where34) and labeled with a rhodamine tag was poured onto the ﬁbers
281until full coverage. The cross-linking of the κ-CA solution was achieved
282with a 5% (wt/v) KCl solution. Immediately after cross-linking, the
283hydrogel disc containing the ﬁbers was ﬁxed with 10% formalin for 40
284min. After ﬁxation, the cell nuclei were stained with DAPI for 20min and
285observed under a confocal laser scanning microscope (CLSM, Olympus,
286Fluoview 1000). YZ and XY projections were performed in order to
287evaluate the cellular distribution throughout the 3D structures.
2882.8. Statistical Analysis. For the swelling ratio and ﬁber diameter
289data, statistical analysis was performed using GraphPad Prism 5.00
290software (San Diego, USA). Statistical diﬀerences (p < 0.05) were
291determined using one-way ANOVA, followed by a Tukey post test.
3. RESULTS AND DISCUSSION
2923.1. Diﬀerent Diameter κ-CA Fibers Formation through
293Ionotropic Gelation. Cell encapsulation techniques using
294hydrogels enable the formation of 3D cell-culture models that
295can potentially replicate tissue organization, which cannot be
296achieved in conventional 2D cultures.37 Since the architecture
297and chemical composition of hydrogels can be easily engineered,
Figure 1.K-CA ﬁbers formed by ionotropic gelation. Needles with diﬀerent gauges, from 18G to 27G, were used to form the hydrogel ﬁbers. (A) Aspect
of ﬁbers using diﬀerent needle gauges. Staining with methylene blue was performed for contrast purposes. (B) Depending on the needle gauge, ﬁbers
diameter spanned from 1.25 mm down to 0.5 mm.
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298 they can be used as tools and platforms to design capture/release
299 of cells in/from 3D tissue-engineered constructs.38
300 Thus, we aimed to develop hydrogel microﬁbers by making
301 use of a simple and straightforward procedure that enables cell
302 encapsulation in a controlled distribution pattern, without
303 jeopardizing their phenotype and functionality. Among the
304 natural origin polymers, such as alginate,14,13 collagen,15 gellan
305 gum,16,39 or hyaluronic acid40 that have been used to obtain
306 ﬁbers through wet spinning technique, κ-CA stands out due to its
307 GAG-like features, reversible temperature and ionic gelation
308 properties and intrinsic sheer thinning behavior, particularly
309 thixotropic. This means that upon applied stress the organization
310 of κ-CA chains is disrupted, but it will reset once the deformation
311is removed.25 This property renders the use of κ-CA hydrogels as
312injectable matrixes, as they can be easily extruded through narrow
313needles without aﬀecting the structure or the entrapped
314biomacromolecules or cells.41,42 Taken together, the gelation
315properties of κ-CA enable the formation of gels in diﬀerent
316shapes, including ﬁbers, highlighting therefore the versatility of κ-
317CA processability.8
318In the present study, the possibility of producing κ-CA ﬁbers
319with diﬀerent diameters was ﬁrst investigated. To obtain the ﬁber
320shape, κ-CA was extruded directly into the coagulation bath,
321where the cross-linking of the polymer solution occurred.
322Variation of the diameter depended on the needle gauge used to
323 f1extrude the κ-CA solution into the coagulation bath (Figure 1A).
Figure 2. Production of CHT coated κ-CA hydrogel ﬁbers. (A) Variation of the pH relative to the β-glycerophosphate (βGP)/chitosan (CHT) ratio.
With the addition of βGP, the CHT solutions reach physiologically relevant conditions (pH 5.5−6). Above this point the precipitation of CHT occurs
(dark gray area). (B) With the addition of βGP, the zeta potential of CHT solution is dramatically aﬀected. The zeta potential of κ-CA solutions,
measured at pH = 5.5, was used as reference (approximately−40 mV). Values reported correspond to n = 10. (C) Schematics of the production of CHT
coated κ-CA hydrogel ﬁbers. The process involves the formation of ﬁbers by ionotropic gelation in a KCl coagulation bath, followed by their immersion
in an optimized CHT solution. (C1) The presence of the CHT coating was conﬁrmed by staining the ﬁbers with Eosin Y which speciﬁcally binds to
CHT.
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324 Using needle gauges ranging from 18 to 27G, it was possible to
325 obtain ﬁbers with diﬀerent diameters, directly proportional with
326 the internal diameter of the needles (838−210 μm). The ﬁbers
327 produced within these settings had a diameter ranging from 500
328 to 1250 μm (Figure 1B), making them appealing for further
329 applications.13,14,43 These trends were in agreement with
330 previous reports for hydrogel ﬁbers obtained via wet spinning18
331 or other techniques.14
332 Taking into consideration that a microsized architecture
333 enables nutrients and oxygen diﬀusion, crucial for the cellular
334 performance, we decided to further explore the potential κ-CA
335 ﬁbers with the smallest diameters, obtained by the extrusion of κ-
336 CA solutions through the 25G and 27G needles.
337 3.2. κ-CA Fibers Can Be Coated with CHT through
338 Polyelectrolyte Complexation. Although encouraging results
339 have shown the potential of using κ-CA in TE applications, the
340 ionically cross-linked κ-CA hydrogels exhibit high swelling ratios.
341 It is possible that the culture medium destabilizes the physically
342 cross-linked network, as a result of the uncontrollable and
343 permanent exchange of K+ ions with other positive ions present
344 in the physiological environment.24 This allows the inner
345 network to continuously expand, and consequently become
346 loose and mechanically weak.25,44 If one envisions the prolonged
347 culture periods or the maintenance of initial microfeatures of the
348 hydrogels, such as shape, size, and stability, the reinforcement of
349 the structure is an impetus.
350 Several methodologies have been employed,18,25,27 including
351 the formation of polyelectrolyte complexes formed by the ionic
352 interaction between oppositely charged polyelectrolytes. We
353 hypothesized that, by coating the κ-CA hydrogels ﬁbers with
354 CHT, we would be able to stabilize the ﬁbers structure. CHT, a
355 β-1,4-linked D-glucosamine and N-acetyl-D-glucosamine, is one
356 of the few positively charged natural-origin polysaccharides and,
357 thus, is widely used as a polycation for the formation of
358 polyelectrolyte complexes. Additionally, its appealing properties
359 such as biocompatibility, biodegradability, low toxicity, and
360 relatively low production cost from abundant sources endorse its
361 use for TE strategies.45
362Since the amino groups of CHT have a pKa value of 6.5−6.8,
46
363their protonation occurs in acidic solutions with a charge density
364dependent on pH and degree of acetylation. Besides causing
365CHT to become water-soluble, the protonated groups can
366readily bind to the negatively charged groups (carboxylic acid,
367hydroxyl, or sulfate) of other polymers, to form polyelectrolyte
368complexes. Thus, our hypothesis was that the protonated amino
369groups of CHT would bind to the available negatively charged
370sulfate groups of κ-CA and form an acid−base type of
371polyelectrolyte complex. Therefore, we have deliberately chosen
372shorter gelation times for the formation of κ-CA ﬁbers (10 min
373over standard 30 min18,41), so that the ﬁber shape was retained,
374without neutralizing all sulfate groups.
375However, since the growth of cells is usually optimal when the
376microenvironment is buﬀered at a pH in the range 7.2−7.4,47 the
377low pH values at which CHT dissolves might compromise their
378viability. Thus, we explored the possibility of increasing the pH of
379CHT solutions without jeopardizing their solubility, by adding a
380week base, βGP,36 to the solutions. We noticed that, by gradually
381adding βGP to the CHT solutions, the pH slowly increased
382 f2without evident signs of precipitation (Figure 2A). Nevertheless,
383upon reaching the pKa value, precipitation occurred.
384One concern associated with the increase of pH was that the
385amino groups of CHT would be deionized, which would weaken
386their binding aﬃnity to the oppositely charged κ-CA, jeopard-
387izing the stability of the layer. To determine whether this was the
388case, we evaluated the electrical charge of the CHT solution upon
389addition of βGP, and consecutively upon increase of pH, by
390measuring the zeta potential. As expected, with the increase of
391the pH, the overall charge of the CHT solution decreased,
392though still remaining within the positive range (approximately
393+10 eV) (Figure 2B). These ﬁndings indicate that with the pH
394modiﬁcation, the protonation of amino groups still occurs, and
395consequently CHT would continue to act as a polycation, being
396suitable for PEC with κ-CA. In the perspective of coating cell-
397loaded κ-CA ﬁbers, pHof 5.5, where no signs of precipitation
398were observed and the overall charge of CHT was positive, was
399considered the most suitable condition.
Figure 3. Swelling behavior of κ-CA ﬁbers, without (w/o) and with (w/) CHT coating, in culture medium (DMEM). (A) Swelling ratio increases over
time for the ﬁbers without CHT coating. On the other side, the CHT coating stabilizes the hydrogel ﬁbers, hampering their swelling. Values correspond
to average (n = 3)± standard deviation. “∧̂” corresponds to a statistical diﬀerence (p < 0.05) when compared to day 0 and day 7 values of the κ-CA ﬁbers
without coating. (B) The diameter of the developed ﬁbers is a direct consequence of the swelling behavior. Thus, the uncoated κ-CA ﬁbers show a
signiﬁcant increase in the ﬁber diameter along time (***p < 0.001), while the diameter of coated ﬁbers remains constant.
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400 The formation of the polyelectrolyte complexes relies on the
401 interaction between the available negatively charged sulfate
402 groups of κ-CA and the protonated amino groups of CHT
403 (Figure 2C). Thus, the immersion of κ-CA ﬁbers in the
404 optimized CHT solution led to the formation of a localized CHT
405 nanosized layer, which was in agreement with previously
406 published data.29−33 The presence of the CHT coating was
407 conﬁrmed by the intense pink coloration observed only on the
408 coated ﬁbers after staining with Eosin Y, which speciﬁcally stains
409 CHT48 (Figure 2C−C1 inset). From a practical standpoint,
410 CHT coated ﬁbers, when compared with the uncoated ﬁbers,
411 were easier to separate and handle despite their small diameters.
412 3.3. CHT Coated κ-CA Fibers Depict Improved Stability.
413 In the context of TE, it is important to evaluate the behavior of
414 these ﬁbers in conditions similar to the in vivo microenviron-
415 ment. Swelling properties of hydrogels directly aﬀect the overall
416 features of the polymeric network (shape, size, and mechanical
417stability). Thus, we aimed to evaluate to which extent the
418swelling ratio of the developed ﬁbers aﬀects their overall
419diameter, and whether the presence of CHT provides stability
420to the ﬁbers. We performed swelling studies by maintaining the
421coated and uncoated ﬁbers in culture medium, which consists of
422a collection of ions and proteins that could destabilize the κ-CA
423hydrogel network.41
424Our ﬁndings showed that the swelling ratios of ionically cross-
425linked κ-CA ﬁbers signiﬁcantly increased with time (p < 0.001)
426 f3(Figure 3A). The destabilization of the ionically cross-linked κ-
427CA network is likely to occur due to the continuous exchange of
428K+ ions entrapped within the network with other ions present in
429the culture medium. In fact, similar results have been reported for
430ionically cross-linked alginate
24 and gellan gum,44 where
431prolonged immersion in culture medium led to the weakening
432of the network and, consequently, to its collapse.
Figure 4. Physicochemical characterization of the freeze-dried ﬁbers. (A) SEMmicrographs depict the alteration of ﬁber morphology in culture medium
(DMEM) over time. The structure of the uncoated ﬁbers is not stable and disintegrates after 21 days (A1-A3-A5), while the CHT coating exhibits a
protective role that hinders the disintegration of the ﬁbers and therefore enhances their stability (A2-A4-A6). (B) The presence of CHT was evaluated
along time by tracing the amounts of nitrogen (from the−NH2 groups of CHT) present on the surface of the ﬁbers. The element was detected until day
21, suggesting that CHT was still present on the ﬁbers. The deﬁned squares in the SEM micrographs represent the area where the magniﬁcation and
elemental analysis were performed.
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433 However, CHT coated ﬁbers exhibited a stable swelling ratio
434 over time, signiﬁcantly inferior to that of the uncoated ﬁbers (p <
435 0.001). This behavior can be due to the strong protective coating
436 layer, preventing the ﬁber swelling. A similar behavior was
437 described in other studies, concerning the use of CHT in
438 combination with alginate to form a layer of wrapping alginate
439 beads for the controlled release of drugs.29
440 As a consequence, the diameter of CHT coated ﬁbers was
441 maintained constant over time, while the uncoated ﬁbers
442 exhibited an increase in their diameter (Figure 3B). Even
443 more, in terms of manipulation, the uncoated ﬁbers became soft
444 and easy to break, while the coated ones were stable over the long
445 term and easy to handle, without obvious damage to their
446 integrity.
447 The closer evaluation of the ﬁber morphology by SEM
448 revealed that the uncoated ﬁbers started to lose their integrity
f4 449 around day 14 (Figure 4A1−3−5), as predicted by the swelling
450 ratio results (Figure 3A). By contrast, the CHT coated ﬁbers
451 exhibited a rougher surface, displaying a mesh-like wrapping
452 around an open-pore κ-CA core. These ﬁbers maintained their
453 shape, size, and integrity until day 21, when small cracks become
454 visible on their surface (Figure 4A2−4−6). The presence of the
455 CHT coating was further demonstrated by tracing the N content
456 on the surface of the CHT-coated κ-CA ﬁbers by EDS/EDX
457 (Figures 4B) over time. Its detection up to 21 days suggested that
458 the CHT-κ-CA electrostatic interactions are strong enough to
459 withstand the presence of other ions and proteins present in the
460 culture medium, leading to a robust and stable structure.
461 3.4. CHT Coating of the Cell-Loaded κ-CA Fibers Does
462 Not Aﬀect the Endothelial Diﬀerentiated SSEA-4+hASCs
463 Phenotype in the Long Term. Recently, several cell types,
464 such as human adipose derived stem cells, human nasal
465 chondrocytes, ATDC5 chondrocytic cell line, and L929
466 ﬁbroblast cell line, were encapsulated within k-CA hydrogels,
467 processed in diﬀerent shapes (ﬁbers, beads, discs), with positive
468 results in terms of viability, cellular metabolism, proliferation,
469 and diﬀerentiation.41,49,50 Herein, for the ﬁrst time, we proposed
470 the encapsulation of microvascular-like ECs within k-CA
471hydrogel ﬁbers as building blocks of vascularized bone tissue
472engineered constructs. Pre-vascularization of engineered con-
473structs by using progenitor/endothelial cells has been considered
474the most promising strategy to address the vascularization of
475large constructs.51 However, the use of human cells has been
476hampered by the limited sources and reduced yields.52 Our
477earlier work34 has shown that the SSEA-4+ subpopulation,
478selected among the heterogeneous stromal vascular fraction of
479human adipose tissue, can be diﬀerentiated toward both
480endothelial and osteogenic lineages. Moreover, SSEA-
4814+hASCs-derived ECs hold features of microvascular ECs that
482trigger the formation of 3D vascular networks within engineered
483constructs. Therefore, we have taken advantage of our
484knowledge to obtain ECs from SSEA-4+ subpopulation
485(Supporting Information (SI) Figure 1) to develop cell-laden
486κ-CA-based hydrogel ﬁbers to be used as 3D cellular carriers.
487SSEA-4+hASCs-derived ECs were encapsulated within the κ-CA
488and CHT coated κ-CA ﬁbers with 2 diﬀerent diameters and
489 f5cultured for a period of 21 days (Figure 5A).
490As the encapsulation procedure requires several steps that
491could lead to reduced cellular performance,53,54 the direct eﬀect
492of the experimental conditions over the viability of the
493encapsulated cells was assessed. Independently of the size and
494whether ﬁbers were coated or not, the majority of the
495encapsulated cells were viable (average >65%, SI Figure 2) and
496homogeneously distributed within the ﬁbers (Figure 5B),
497suggesting that the production of ﬁbers (ionotropic gelation
498and PEC) was mild enough.
499Additionally, along the culture time and independently of the
500conditions, viable cells were predominantly observed within the
501 f6ﬁbers (Figure 6). A slight decrease in cellular viability was
502noticed, so that by day 21, viable cells comprised 60% of the total
503cells (SI Figure 2). However, this drop was not as signiﬁcant as
504reported in previous studies that associated this outcome with
505the slow diﬀusion of nutrients caused by the sample thickness
506and/or cross-linking mechanism.25,55,56 It might be due to the
507fact that ﬁber-shaped hydrogels were characterized by a larger
508surface area than disc shaped units, and as a consequence, a faster
Figure 5. Encapsulation of SSEA-4+hASCs-derived ECs into κ-CA ﬁbers. (A) Schematics of the encapsulation procedure and experimental setup. (B)
The assessment of cell viability (live (green)/dead (red)) 24 h after encapsulation shows that the cells were not aﬀected by the processing method, nor
by the size and CHT coating of the ﬁbers. Cell nuclei were counterstained with DAPI (blue).
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509 diﬀusion of nutrients and oxygen to the core of the sample could
510 occur.57 It has also been suggested that the ions needed for
511 hydrogel formation may inﬂuence the cellular viability; never-
512 theless, the ﬁbers reported herein are formed via a partial cross-
513 linking process, by shorter exposure times to K+ treatment than
514 previously reported.18,58 The additional CHT coating, that was
515 shown to prevent the ﬁbers from swelling, did not aﬀect viability.
516 From the SEM images it was possible to notice that the CHT
517 layer was displayed as a mesh wrapped around the ﬁber,
518 preventing it from swelling, but enabling diﬀusion.
519 The optical analysis of the cell-loaded uncoated ﬁbers showed
520 an increase in their diameter and subsequent disintegration, in
521 agreement with the results obtained with acellular ﬁbers.
522 Concisely, at day 7, uncoated ﬁbers were intact, with a well-
523 delimited smooth surface; however, at day 14, they presented
524 signs of disintegration. This allowed the entrapped cells to
525 “escape” from the ﬁbers and adhere to the well and proliferate
526 (Figure 6A1−C1). In opposition, the CHT coating delayed the
527 disintegration of ﬁbers, as they maintained their initial diameter
528 and their surface did not present disruptions up to day 14 (Figure
529 6A2−B2). Only at the last time point did small cracks become
530visible, and consequently, EC colonies were observed on the
531bottom of the well (Figure 6C2).
532Beside potentially aﬀecting cellular viability,7 cell encapsula-
533tion procedures and prolonged culture might also compromise
534the cell’s phenotype or functionality.20,59 In order to address this
535question, cells were retrieved from the ﬁbers, after culturing for
53621 days, and seeded into tissue culture ﬂasks. Cells were able to
537 f7adhere and organize into small endothelial-like colonies (Figure
538 f77A) and, more importantly, maintained their ability to form
539tubular-like structures when seeded on Matrigel (Figure 7B).
540Moreover, when screened for the initial cell surface marker panel,
541cells were shown to be CD105+/CD73+/CD31+/CD34+/
542CD45−/CD90−, a signature that matches the one registered
543prior encapsulation. Taken together, these results show that the
544encapsulation process, followed by the prolonged culture of cells
545within ﬁbers and their retrieval, did not aﬀect the phenotype and
546in vitro functionality of ECs.
547Overall, as κ-CA ﬁbers exhibit high swelling ratios, the
548weakening of the network occurred and, consequently, cells were
549able to escape from the ﬁbers. CHT coating maintained the ﬁber
550diameter, delaying their disintegration and the consequent
551release of cells into the surrounding environment. Nonetheless,
Figure 6. Evaluation of the cell-laden κ-CA hydrogel ﬁbers along 21 days of culture. The viability of encapsulated cells (live/dead/) was maintained
during the culture time in all conditions. (A) At day 7, independently of the conditions, ﬁbers were intact, without displaying signs of disintegration. (B1)
At day 14, cells escaped the uncoated ﬁbers and small endothelial-like colonies could be observed at the bottom of the well. By day 21 (C1), ﬁbers lose
their integrity (arrows), allowing further release of cells into the well plate. Contrarily, the CHT coating (w/CHT) delayed the disintegration of the
ﬁbers, hence the release of the cells (B2 and C2). At day 21, the coated ﬁber diameter did not alter; however, small cracks (arrows) were observed along
the ﬁbers allowing the release of the cells. Cell nuclei were counterstained with DAPI (blue).
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552 the CHT layer was still permissive to culture medium, allowing
553 the diﬀusion of its components, as suggested by the subsequent
554 remarkable results concerning the viability and phenotype of
555 encapsulated cells. These ﬁndings further demonstrate the
556 potential of using these ﬁbers as EC carriers within diﬀerent TE
557 constructs.
558 3.5. Cell-Loaded κ-CA-Based Fibers Can Act as Building
559 Blocks within 3D Hydrogel Constructs. In vitro 3D co-
560 culture platforms provide a scalable and ﬂexible approach to
561 evaluate the indirect interactions between multiple-cell types in
562 highly deﬁned settings, enabling us to address speciﬁc cellular
563 behaviors and the formation of complex tissue-like analogs.
564 Simultaneously, the integration and assembly of cell-laden
565 templates as building blocks within 3D constructs may allow
566 the development of replicas of complex tissues to use in TE
567 approaches. Herein, we proposed a straightforward method to
568 integrate the κ-CA-based ﬁbers enclosing SSEA-4+hASCs-
569 derived ECs, within a 3D hydrogel containing SSEA-4+hASCs-
570 derived osteoblast-like cells, as heterotypic constructs of interest
571 for bone TE.Within this approach, we took advantage of the ease
572 preparation of cell-loaded κ-CA ﬁbers, to recreate the cellular
573 indirect communication at a 3D scale. Thus, cell-loaded ﬁbers,
574 used as building blocks, were assembled within a κ-CA hydrogel
f8 575 disc by simply laying them in a Petri dish (Figure 8). They could
576 be singled out or stacked in a random or organized manner
577 (Figure 8A). When the cell-laden ﬁbers were integrated in a
578 hydrogel disc containing osteoblast-like cells, the formation of a
579 3D heterotypic platform with a deﬁned cellular topography
580 suitable for bone-vascularization strategies was achieved (Figure
581 8B−C). The proposed system was entirely formed by a κ-CA
582 matrix, with a controlled spatial distribution of the two cell types
583 derived from the same source. The ﬁbers are expected to act both
584as cell-reservoirs and structurally deﬁned arrangements in the
585surrounding matrix. Within the context of bone TE, further
586experiments aim to deeply assess the cellular interactions within
587the 3D structure and the consequent outcome, both concerning
588the outﬂow of ECs triggered by the crosstalk with osteoblast
589cells,60,61 as well as osteogenic matrix deposition and
590mineralization. This could eventually lead to the organization
591of ECs within the osteoblast-containing matrix, leading to an
592improvement in the osteogenic outcome.
593For the immediate integration of ﬁbers in a secondary matrix,
594the CHT coating does not provide additional advantages, as the
595secondary matrix will already hold the ﬁbers in place.
596Nevertheless, the CHT coating proves to be crucial for
597prolonged culture periods that are relevant when using this
598approach to study indirect interactions between multiple-cell
599types and/or for those 3D systems in which the accuracy of the
600initial parameters (shape, size, swelling, mechanical stability) is
601crucial. For instance, it could be possible to create a 3D co-culture
602system based on coated cell-laden κ-CA ﬁbers by seeding another
603cell type on top of the ﬁbers.
4. CONCLUSIONS
604The development of chitosan (CHT) reinforced κ-carrageenan
605(κ-CA) ﬁbers using a two-step procedure, under cell-friendly
606experimental settings, aiming at homogeneous immobilization of
607cells is herein reported. The diameter of the ﬁbers could be easily
608tuned by selecting the appropriate needle gauge during
609processing. The presence of the CHT coating enhanced the
610stability of the ﬁbers and their diameter was maintained constant
611by restraining their swelling. Moreover, these ﬁbers support the
612viability and functionality of encapsulated cells during long-term
613culturing, enabling their use as cell-delivery systems within 3D
Figure 7. Endothelial phenotype of cells retrieved from the ﬁbers after 21 days of culture. (A) After retrieval of cells through degradation of the ﬁbers,
and their subsequent seeding, cells adhered and formed small colonies, characterized by close contact between cells (live/cytoskeleton/nuclei). (B)
Cells maintained their ability to form tubular-like structures (green) when seeded on Matrigel (C) and the expression of the initial endothelial
phenotype-associated panel of markers. Cell nuclei were counterstained with DAPI (blue).
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614 tissue engineering constructs. Furthermore, using a bottom-up
615 approach, these ﬁbers can be used as building blocks for the
616 development of suitable 3D platforms of independently
617 organized heterotypic cell-containing hydrogels, relevant for
618 TE approaches.
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